4.7 Review

Accelerated aging in bipolar disorder: A comprehensive review of molecular findings and their clinical implications

Journal

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
Volume 112, Issue -, Pages 107-116

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neubiorev.2020.01.035

Keywords

Bipolar disorder; Mania; Depression; Aging; Telomere length; DNA methylation; Epigenetics; mtDNA; Oxidative stress; Inflammation

Funding

  1. UTHealth Consortium on Aging, The University of Texas Houston Retiree Organization (UTHRO)
  2. University of Texas Health Science Center at Houston (UTHealth) - Center of Excellence on Mood Disorders (USA)
  3. Pat Rutherford Jr.
  4. John S. Dunn Foundation
  5. Anne and Don Fizer Foundation Endowment for Depression Research - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
  6. Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)
  7. Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC)
  8. Instituto Cerebro e Mente
  9. University of Southern Santa Catarina (UNESC)
  10. UTHealth Center for Clinical and Translational Sciences (CCTS)

Ask authors/readers for more resources

Bipolar disorder (BD) has been associated with clinical signs of accelerated aging, which potentially underlies its association with several age-related medical conditions, such as hypertension, metabolic imbalances, dementia, and cancer. This paper aims to comprehensively review evidence of biological aging in BD and explore findings and controversies related to common biological clocks in patients, including telomere length, DNA methylation, mitochondrial DNA copy number, inflammation, and oxidative stress. Our results suggest a complex interplay between biological markers and a potential key role of environmental factors, such as childhood trauma and psychological stress, in determining premature aging in patients. Moreover, given its multifactorial nature, our summary evidences the need for further studies incorporating clinical evidence with biomarkers of accelerated aging in BD. Results of this review strongly suggest BD as an accelerated aging disease seen in both clinical and molecular aspects. Understanding the pathophysiology of aging in BD may ultimately lead to identification of pathways that can be targeted for prevention of premature aging in patients and early onset of aging-related conditions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available